138 related articles for article (PubMed ID: 32330994)
1. Gastrointestinal Ultrasound Can Predict Endoscopic Activity in Crohn's Disease.
Sævik F; Gilja OH; Nylund K
Ultraschall Med; 2022 Feb; 43(1):82-89. PubMed ID: 32330994
[TBL] [Abstract][Full Text] [Related]
2. Utility of bowel ultrasound in assessing disease activity in Crohn's disease.
Kakkadasam Ramaswamy P; Vizhi N K; Yelsangikar A; Krishnamurthy AN; Bhat V; Bhat N
Indian J Gastroenterol; 2020 Oct; 39(5):495-502. PubMed ID: 33201441
[TBL] [Abstract][Full Text] [Related]
3. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
5. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.
Schaffer T; Schoepfer AM; Seibold F;
J Crohns Colitis; 2014 Sep; 8(9):1125-32. PubMed ID: 24636141
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Simple Ultrasound Activity Score for Crohn's Disease.
Sævik F; Eriksen R; Eide GE; Gilja OH; Nylund K
J Crohns Colitis; 2021 Jan; 15(1):115-124. PubMed ID: 32504533
[TBL] [Abstract][Full Text] [Related]
7. Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease.
Zittan E; Kabakchiev B; Kelly OB; Milgrom R; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
J Crohns Colitis; 2017 May; 11(5):543-548. PubMed ID: 28453763
[TBL] [Abstract][Full Text] [Related]
8. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
9. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.
Melmed GY; Dubinsky MC; Rubin DT; Fleisher M; Pasha SF; Sakuraba A; Tiongco F; Shafran I; Fernandez-Urien I; Rosa B; Papageorgiou NP; Leighton JA
Gastrointest Endosc; 2018 Dec; 88(6):947-955.e2. PubMed ID: 30086261
[TBL] [Abstract][Full Text] [Related]
10. Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.
Verdejo C; Hervías D; Roncero Ó; Arias Á; Bouhmidi A; Lorente R; Salueña I; Lucendo AJ
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1521-1527. PubMed ID: 30303822
[TBL] [Abstract][Full Text] [Related]
11. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
E Penna FGC; Rosa RM; da Cunha PFS; de Souza SCS; de Abreu Ferrari ML
BMC Gastroenterol; 2020 Feb; 20(1):35. PubMed ID: 32054445
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 and inflammatory activity in newly onset Crohn's disease.
Grimstad T; Kvivik I; Kvaløy JT; Aabakken L; Omdal R
Scand J Gastroenterol; 2018 Dec; 53(12):1453-1458. PubMed ID: 30625276
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease.
Brand EC; Elias SG; Minderhoud IM; van der Veen JJ; Baert FJ; Laharie D; Bossuyt P; Bouhnik Y; Buisson A; Lambrecht G; Louis E; Pariente B; Pierik MJ; van der Woude CJ; D'Haens GRAM; Vermeire S; Oldenburg B;
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1704-1718. PubMed ID: 31881273
[TBL] [Abstract][Full Text] [Related]
15. Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
[TBL] [Abstract][Full Text] [Related]
16. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
17. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
[TBL] [Abstract][Full Text] [Related]
18. Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy.
Kawashima K; Ishihara S; Yuki T; Fukuba N; Sonoyama H; Kazumori H; Yamashita N; Tada Y; Kusunoki R; Oka A; Oshima N; Mishima Y; Moriyama I; Kinoshita Y
Inflamm Bowel Dis; 2017 Nov; 23(11):2027-2034. PubMed ID: 28817462
[TBL] [Abstract][Full Text] [Related]
19. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
[TBL] [Abstract][Full Text] [Related]
20. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
